Associated tags: Digital, Safety, Human, Heart, CAE, Pescetarianism, Humanetics, Research, Health, Defense, Pharmaceutical, COVID-19, Software, BIO, Patient, Biotechnology, Radiation, Science, Clinical Trials, Other Defense, Pharmaceutical industry, Hardware, Oncology
Locations: EUROPE, GERMANY, MINNESOTA, ASIA, NEW YORK, AUSTRIA, NORTH CAROLINA, MARYLAND, FORT DETRICK, HOLCOMB, KOSOVO, IRAQ, UNITED STATES, NORTH AMERICA, MICHIGAN, RYE BEACH, OHIO, HURON, SPAIN, INDIA, FRANCE, CHINA, ITALY, MEXICO
Humanetics Corporation, a clinical-stage specialty pharmaceutical company developing radioprotectant drugs for warfighters and cancer patients, is presenting a corporate overview and details on its promising lead radioprotective drug candidate, BIO 300, at the prestigious Biotechnology Innovation Organization (BIO) International Convention in San Diego, CA next week.
Key Points:
- Humanetics Corporation, a clinical-stage specialty pharmaceutical company developing radioprotectant drugs for warfighters and cancer patients, is presenting a corporate overview and details on its promising lead radioprotective drug candidate, BIO 300, at the prestigious Biotechnology Innovation Organization (BIO) International Convention in San Diego, CA next week.
- This convention, known for its global reach and influence, provides a platform for industry leaders to showcase their innovations.
- Ronald J. Zenk, Chief Executive Officer, will present this information on Monday, June 3, 2024 (1:30 pm Company Presentation Theatre 3).
Electronic Design Automation,
Robotics,
Engineering,
Defense,
Consumer Electronics,
Technology,
Aerospace,
Logistics,
Supply Chain Management,
Manufacturing,
Mobile,
Wireless,
Retail,
Satellite,
Audio,
Video,
Government Technology,
Artificial Intelligence,
Transport,
Other Technology,
Software,
Wearables,
Mobile Technology,
Other Defense,
Hardware,
Partnership,
HITEC,
BAE,
BAE Systems,
Multimedia,
Electronic Systems HITEC Sensors today announced it received the BAE Systems ‘Partner 2 Win’ Supplier of the Year award.
Key Points:
- HITEC Sensors today announced it received the BAE Systems ‘Partner 2 Win’ Supplier of the Year award.
- HITEC Sensors was selected from a pool of suppliers that delivered exceptional performance and contributions to supply chain success for BAE Systems’ Electronic Systems sector in 2023.
- View the full release here: https://www.businesswire.com/news/home/20240531049861/en/
HITEC Sensors received the BAE Systems ‘Partner 2 Win’ Supplier of the Year award (Photo: Business Wire)
George Low, Vice President & Managing Director of HITEC Sensors, commented, “We are honored to win the 2023 Supplier of the year award and proud to be a Gold Supplier for BAE Systems.
- “The development and manufacturing of BAE Systems’ cutting-edge technology is only possible thanks to our best-in-class supply partners,” said Ray Brousseau, Vice President of Operations, Electronic Systems.
Technology,
Automotive,
General Automotive,
Vehicle Technology,
Automotive Manufacturing,
Manufacturing,
Other Automotive,
Software,
Hardware,
Table tennis rubber,
Human resources,
Safety,
NHTSA,
Pescetarianism,
Crash,
Child,
Multimedia,
Female,
Road The operation experienced substantial growth, prompting the transition to a more expansive manufacturing site in Huron to accommodate the increasing demand.
Key Points:
- The operation experienced substantial growth, prompting the transition to a more expansive manufacturing site in Huron to accommodate the increasing demand.
- Located in Erie County, the 45,000 square foot facility was the first of its kind, designed specifically for the manufacturing of crash test dummies.
- To commemorate its 15th year of manufacturing ATDs in Huron, Ohio, Humanetics has erected a billboard on Route 2 east before the Rye Beach road exit.
- As a proud member of the Huron community, Humanetics looks forward to continuing its legacy of innovation and community involvement for many years to come.
Automotive Manufacturing,
Manufacturing,
General Automotive,
Automotive,
Engineering,
Heart,
TRW,
Karmann,
Visteon,
Multimedia,
Humanetics,
Meritor Humanetics is excited to announce that Bruno Brun is joining Humanetics as VP Global Operations, based in Farmington Hills, reporting to Mark Westen, President Humanetics Safety.
Key Points:
- Humanetics is excited to announce that Bruno Brun is joining Humanetics as VP Global Operations, based in Farmington Hills, reporting to Mark Westen, President Humanetics Safety.
- Bruno will be responsible for the global manufacturing and operations relating to our physical hardware.
- Bruno also brings a truly global perspective to manufacturing having worked in France, China, Spain, Italy, India and Mexico, while predominantly based in Detroit.
- Bruno understands these challenges of introducing new production lines for low volume, complex manufacturing across multiple facilities,” said Mark Westen, President Humanetics Safety.
Automotive Manufacturing,
Technology,
Aerospace,
Manufacturing,
Software,
Other Manufacturing,
Safety,
Original equipment manufacturer,
ATD,
Pescetarianism,
Multimedia We are excited to announce Paul Lemmen is returning to Humanetics as Global Business Development Manager.
Key Points:
- We are excited to announce Paul Lemmen is returning to Humanetics as Global Business Development Manager.
- Paul first joined Humanetics in 1999 and led the development of numerous programs like the FLexPLi, Q Dummies and THORAX for THOR ATDs.
- Paul will join the Humanetics Safety team that is responsible for developing the next generation of advanced ATDs and will work closely together with Humanetics Digital developing the integrated digital platforms that will drive improved performance and efficiency in the digital ATD lab.
- View the full release here: https://www.businesswire.com/news/home/20240423077668/en/
Mark Westen, President Humanetics Safety commented: “Paul has been a key individual in the safety community working closely with NCAPs, OEMs, regulators, and Tier 1 suppliers to drive innovation in vehicle safety and ATD technology.
Retrieved on:
Wednesday, February 7, 2024
Law Enforcement,
Emergency Services,
General Health,
Public Policy,
Government,
Science,
Military,
Clinical Trials,
Biotechnology,
Health,
Other Science,
Research,
Other Defense,
Contracts,
Defense,
Radiology,
Pharmaceutical,
Homeland Security,
Oncology,
Humanetics,
BIO,
Biotechnology Innovation Organization,
Conference,
Growth,
Pharmaceutical industry Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, has announced that it will present and participate in several investor and partnering conferences in February.
Key Points:
- Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, has announced that it will present and participate in several investor and partnering conferences in February.
- The potential audience includes tens of thousands of individual and institutional investors, investment advisors, and analysts.
- BIO CEO & Investor Conference, February 26-27, 2024, New York, NY
Sponsored by the Biotechnology Industry Organization (BIO), the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded, late-stage private biotech companies.
- Event registration: Register for the BIO CEO & Investor Conference .
Retrieved on:
Tuesday, January 23, 2024
Automotive Manufacturing,
Other Transport,
Manufacturing,
Vehicle Technology,
Transport,
Automotive,
Other Technology,
Software,
Hardware,
Data Management,
Professional Services,
Technology,
Data Analytics,
Other Automotive,
General Automotive,
Apps,
Applications,
Engineering,
Performance & Special Interest,
Multimedia,
Partnership,
Peter Hancock (professor),
Pescetarianism,
Safety,
Human,
Ecosystem Humanetics is a leading provider of physical and digital human safety systems and sensor technologies.
Key Points:
- Humanetics is a leading provider of physical and digital human safety systems and sensor technologies.
- Building on an existing partnership, the two companies will together strengthen the human safety engineering ecosystem and help propel the industry forward by marrying physical and virtual safety solutions with digital twins.
- Humanetics’ digital models of ATDs are highly complementary to, and frequently used with Ansys’ LS-DYNA crash test solution.
- “This partnership with Ansys will jointly enable us to further unleash new levels of innovation in the human safety ecosystem.
Retrieved on:
Tuesday, January 23, 2024
Peter Hancock (professor),
Pescetarianism,
Partnership,
ANSYS,
Crash,
Ecosystem,
Human,
Safety,
Transport,
LS-DYNA,
Video game PITTSBURGH, Jan. 23, 2024 /PRNewswire/ -- Ansys (NASDAQ: ANSS) announced that it has entered into a definitive agreement to acquire a minority ownership interest in Humanetics from Bridgepoint, the global private equity firm that first invested in Humanetics in 2018. The transaction is subject to customary closing conditions and receipt of required regulatory approvals. Humanetics is a leading provider of physical and digital human safety systems and sensor technologies. Building on an existing partnership, the two companies will together strengthen the human safety engineering ecosystem and help propel the industry forward by marrying physical and virtual safety solutions with digital twins.
Key Points:
- Humanetics is a leading provider of physical and digital human safety systems and sensor technologies.
- Building on an existing partnership, the two companies will together strengthen the human safety engineering ecosystem and help propel the industry forward by marrying physical and virtual safety solutions with digital twins.
- Humanetics' digital models of ATDs are highly complementary to, and frequently used with Ansys' LS-DYNA crash test solution.
- "Ansys' partnership will jointly enable us to further unleash new levels of innovation in the human safety ecosystem.
Retrieved on:
Tuesday, December 12, 2023
Biotechnology,
Health,
General Health,
Pharmaceutical,
Oncology,
Health Technology,
Veterans,
Military,
Other Defense,
Defense,
Contracts,
Storm,
Attention,
American Public University System,
MSN,
Research,
Humanetics,
Radiation,
RN,
Certification,
Kosovo Force,
RET,
Patient,
BIO,
BSN,
COVID-19,
University,
DOD,
Operation New Dawn,
Knowledge,
Army nursing,
Nursing,
Management Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, has announced the addition of Major General (Ret.)
Key Points:
- Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, has announced the addition of Major General (Ret.)
- Barbara R. Holcomb, RN, BSN, MSN to its board of directors.
- “General Holcomb brings a wealth of knowledge and relevant experience that strengthens our Board,” said Ronald J. Zenk, Chief Executive Officer at Humanetics.
- Humanetics is currently working under a contract with DOD to position BIO 300 for Emergency Use.
Retrieved on:
Tuesday, November 14, 2023
Health,
Pharmaceutical,
Clinical,
Research,
Delta Omega,
Navy,
Medical corps,
Joint Chiefs of Staff,
Internal medicine,
Patient,
Emergency,
American College,
Gastroenterology,
American College of Physicians,
Chief of staff,
Retirement,
Peraton,
Knowledge,
Pharmaceutical industry,
Management,
Humanetics,
Physician,
Medicine,
Defense Humanetics Corporation, a leading innovator in medical countermeasures, is thrilled to announce the appointment of retired Rear Admiral Dr. Colin Chinn as its new Chief Medical Officer.
Key Points:
- Humanetics Corporation, a leading innovator in medical countermeasures, is thrilled to announce the appointment of retired Rear Admiral Dr. Colin Chinn as its new Chief Medical Officer.
- Dr. Chinn, a distinguished medical professional and military leader, brings a wealth of knowledge and expertise to Humanetics Corporation.
- In his new position as Chief Medical Officer at Humanetics Corporation, Dr. Chinn will guide the company's medical research and development efforts.
- Dr. Chinn expressed his enthusiasm for his new role: “I am honored to join the exceptional team at Humanetics Corporation.
